Literature DB >> 3409165

Screening for upper digestive tract cancer with an occult blood bead detector. Investigation of a normal north China population.

D X Qin1, G Q Wang, F L Yuan, M Z Tang, M S Li, Z L Zhang.   

Abstract

Screening of the general population for cancer of the upper digestive tract using an occult blood bead detector supplemented by fibergastroscopy was able to detect 126 cancers of the esophagus, gastric cardia, and stomach. This screening was carried out in two of the high-risk areas, Yangzhong and Wun counties, located in central eastern and north China. The occult blood bead detector, swallowed and retained in the stomach for 3 minutes, was able to sort out the suspected persons by its coloration from sky blue (+) to dark blue ( ) on removal. The subsequent fibergastroscopy could make a definite diagnosis by biopsy specimen. A preliminary trial performed on patients with established cancers was 100% (18 of 18) positive for stomach cancer and 81% (13 of 16) positive for esophageal cancer. A public survey of the high-risk areas, screening 38,073 normal persons ranging in age from 35 to 70 years, showed positive results in 9204 (24.2%) persons. Subsequent fibergastroscopy carried out in 4023 occult blood bead detector positive persons showed 126 cancers (41 of the esophagus, 46 of the gastric cardia, and 39 of the stomach). Factors influencing the cancer detection rate were sex, age, and degree of positivity of the occult blood bead detector test. Seventy per cent (89 of 126) of the cancers discovered were in an early stage. The occult blood bead detector costs the primary screened person only 30 cents and may be practical for the large-scale screening of cancer of the upper digestive tract in developing areas.

Entities:  

Mesh:

Year:  1988        PMID: 3409165     DOI: 10.1002/1097-0142(19880901)62:5<1030::aid-cncr2820620533>3.0.co;2-s

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Long-Term Follow-Up of a Community Assignment, One-Time Endoscopic Screening Study of Esophageal Cancer in China.

Authors:  Wen-Qiang Wei; Zhi-Feng Chen; Yu-Tong He; Hao Feng; Jun Hou; Dong-Mei Lin; Xin-Qing Li; Cui-Lan Guo; Shao-Sen Li; Guo-Qing Wang; Zhi-Wei Dong; Christian C Abnet; You-Lin Qiao
Journal:  J Clin Oncol       Date:  2015-05-04       Impact factor: 44.544

2.  Laparoscopic resection of submucosal tumor on posterior wall of gastric fundus.

Authors:  Zhong-Wei Ke; Cheng-Zhu Zheng; Ming-Gen Hu; Dan-Lei Chen
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

3.  Efficacy of endoscopic treatment on patients with severe dysplasia/carcinoma in situ of esophageal squamous cell carcinoma: A prospective cohort study.

Authors:  Meng Wang; Changqing Hao; Shuanghua Xie; Shanrui Ma; Qing Ma; Rongshou Zheng; Ru Chen; Xinqing Li; Wenqiang Wei
Journal:  Chin J Cancer Res       Date:  2019-04       Impact factor: 5.087

4.  DNA image cytometry test for primary screening of esophageal cancer: a population-based multi-center study in high-risk areas in China.

Authors:  Meng Wang; Changqing Hao; Qing Ma; Guohui Song; Shanrui Ma; Deli Zhao; Lin Zhao; Xinqing Li; Wenqiang Wei
Journal:  Chin J Cancer Res       Date:  2016-08       Impact factor: 5.087

Review 5.  Strategies for prevention of gastrointestinal cancers in developing countries: a systematic review.

Authors:  Ahmad Zia Shams; Ulrike Haug
Journal:  J Glob Health       Date:  2017-12       Impact factor: 4.413

6.  Evaluating efficacy of screening for upper gastrointestinal cancer in China: a study protocol for a randomized controlled trial.

Authors:  Wanqing Chen; Hongmei Zeng; Ru Chen; Ruyi Xia; Zhixun Yang; Changfa Xia; Rongshou Zheng; Wenqiang Wei; Guihua Zhuang; Xueqin Yu; Jie He
Journal:  Chin J Cancer Res       Date:  2017-08       Impact factor: 5.087

7.  Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China.

Authors:  He Liang; Jin-Hu Fan; You-Lin Qiao
Journal:  Cancer Biol Med       Date:  2017-02       Impact factor: 4.248

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.